post/
17 pages · Updated June 15, 2026
Pages
- DSCSA 2024 Ten-Count Number 2: State Regulators Are Engaging
- DSCSA 2024 Ten-Count: Number 3 – FDA Grants DSCSA Exemption to Connected Trading Partners
- Can DSCSA Really Help Keep Patients Safe?
- Does DSCSA Break or Fix or Not Impact 340B Drug Pricing Programs?
- Are You 100% DSCSA Ready or Ready to Submit an Excemption Request?
- DSCSA 2024 Ten-Count: Number 4 – PDG-FDA-Industry Listening Sessions
- DSCSA 2024 Ten Count: Number 6-Exception Handling Building Resilient Processes
- DSCSA 2024 Ten Count: Number 1 - Counterfeit Ozempic and the Ongoing Fight for Supply Chain Security
- DSCSA 2024: Ten Count: Number 5- Counterfeit Drug Threats in the US Supply Chain
- DSCSA 2024 Ten Count: Number 8- Two-Year Exemption for Small Dispensers
- DSCSA 2024 Ten Count: Number 7-DSCSA Stabilization Period Midway Checkpoint PDG-FDA Joint Public Meeting
- DSCSA 2024 Ten Count: Summary
- Another FDA Warning Letter Regarding DSCSA
- DSCSA 2024 Ten Count: Number 9- FDA 483s
- DSCSA 2024 Ten Count: Number 10- Decommissioning
- Do I Need a "Digital Credential" to comply with DSCSA?
- Dispenser DSCSA Resource Page